Multiple myeloma--intermittent combination chemotherapy compared to continuous therapy.
D000741:Anemia, Aplastic / Q000139:chemically induced; D002986:Clinical Trials as Topic; D003520:Cyclophosphamide / Q000008:administration & dosage* / Q000009:adverse effects; D004338:Drug Combinations; D005069:Evaluation Studies as Topic; D006801:Humans; D007970:Leukopenia / Q000139:chemically induced; D008558:Melphalan / Q000008:administration & dosage* / Q000009:adverse effects; D008875:Middle Aged; D009101:Multiple Myeloma / Q000188:drug therapy* / Q000532:radiotherapy; D010166:Palliative Care; D011446:Prospective Studies; D013902:Radiography, Thoracic; D012189:Retrospective Studies; D013921:Thrombocytopenia / Q000139:chemically induced
D004338:Drug Combinations; D003520:Cyclophosphamide; D008558:Melphalan